Inhaled medication: which device for which patient?

Mario Cazzola, Paola Rogliani

Source: Eur Respir Monogr 2015; 69: 213-223
Journal Issue: Controversies in COPD
Disease area: Airway diseases

Full text journal articleCongress or journal article abstract

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Mario Cazzola, Paola Rogliani. Inhaled medication: which device for which patient?. Eur Respir Monogr 2015; 69: 213-223

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inhaled beta2-agonists in asthma management: an evolving story
Source: Breathe 2016; 12: 375-377
Year: 2016


COPD: Are beliefs about inhaled medication associated with patients’ inhaler technique?
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018



Inhaled corticosteroids in treatment of patients with intermittent bronchial asthma: yes or no?
Source: Eur Respir J 2005; 26: Suppl. 49, 503s
Year: 2005

Inhaled therapies: can they breathe new life into asthma?
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019

Inhaled corticosteroids in COPD: the case against
Source: Eur Respir J 2009; 34: 13-16
Year: 2009


Optimising bronchodilator therapy in COPD: Who, why and when?
Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care
Year: 2019

Inhaled antibiotics: a new tool?
Source: Annual Congress 2009 - Antibiotics and the lung
Year: 2009


Inhaled corticosteroids in COPD: a case in favour
Source: Eur Respir J 2009; 34: 10-12
Year: 2009


Inhaled corticosteroids in COPD: friend or foe?
Source: Eur Respir J, 52 (6) 1801219; 10.1183/13993003.01219-2018
Year: 2018



How can we improve patient use of inhaler devices in COPD?
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011

Is there a problem with inhaled corticosteroid use in COPD?
Source: Virtual Congress 2020 – Airway diseases
Year: 2020


Poor adherence to inhaled corticosteroids in childhood asthma: Don‘t blame (only) the patient
Source: Annual Congress 2011 - Treating childhood asthma
Year: 2011


Inhaled corticosteroids in COPD: the final verdict is…
Source: Eur Respir J, 52 (6) 1801940; 10.1183/13993003.01940-2018
Year: 2018



Inhaled corticosteroids use in patients with bronchiectasis: Data from the EMBARC registry
Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes
Year: 2021



Inhaled corticosteroids in preschool asthmatics: are they effective and who benefits most?
Source: Eur Respir J 2003; 22: Suppl. 45, 534s
Year: 2003

Long-acting bronchodilators in COPD: where are we now and where are we going?
Source: Breathe 2014; 10:110-120
Year: 2014



Inhaler adherence in severe asthma: is there an electronic solution?
Source: Eur Respir J, 51 (1) 1702219; 10.1183/13993003.02219-2017
Year: 2018



What to use INSTEAD of inhaled corticosteroids in COPD?
Source: Eur Respir J 2014; 44: 1391-1393
Year: 2014


Inhaled corticosteroids: a controversial add-on treatment in COPD
Source: Eur Respir J 2010; 36: 973-974
Year: 2010